$48,315,610

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

biotechactiveONGOING · MOD OF 2023 CONTRACT

WORK BEGAN2023-12-18·LATEST ACTION2026-03-17·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50424C00001_7505_-NONE-_-NONE-

Award description

INDUSTRIAL BASE EXPANSION (IBX) FOR METHACRYLIC ACID FOR KEY CHEMICALS.

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Expand domestic industrial capacity to produce methacrylic acid, a key chemical used in pharmaceutical and medical device manufacturing.

Sub-sectors

pharmaceutical-manufacturingindustrial-base-expansionchemical-precursors

Why this matters

Strengthens U.S. pharmaceutical supply chain resilience by reducing dependence on foreign chemical precursor suppliers for critical medicines.

Supply-chain signal

Signals investment in upstream chemical manufacturing to support downstream pharmaceutical and medical device producers reliant on methacrylic acid.

U.S.–China competition angle

Reduces U.S. vulnerability to Chinese dominance in specialty chemical production, a critical input for domestic pharma manufacturing.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002241.

Period of performance

Start

2023-12-18

End

2026-12-15

Status

activein 210 days

Recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75A50424C00001_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.